Kelyniam Global (Kelyniam Global) Change In Receivables : $0.00 Mil (TTM As of Mar. 2008)

View and export this data going back to 2008. Start your Free Trial

What is Kelyniam Global Change In Receivables?

Kelyniam Global's change in receivables for the quarter that ended in Mar. 2008 was $0.00 Mil. It means Kelyniam Global's Accounts Receivable stayed the same from Dec. 2007 to Mar. 2008 .

Kelyniam Global's change in receivables for the fiscal year that ended in Dec. 2007 was $0.00 Mil. It means Kelyniam Global's Accounts Receivable stayed the same from Dec. 2006 to Dec. 2007 .

Kelyniam Global's Accounts Receivable for the quarter that ended in Mar. 2008 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Kelyniam Global's Days Sales Outstanding for the three months ended in Mar. 2008 was 18.25.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Kelyniam Global's liquidation value for the three months ended in Mar. 2008 was $-0.14 Mil.

Kelyniam Global Change In Receivables Historical Data

The historical data trend for Kelyniam Global's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kelyniam Global Change In Receivables Chart

Kelyniam Global Annual Data

Trend

Dec06

Dec07

Change In Receivables

Kelyniam Global Quarterly Data
	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-

Kelyniam Global Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Kelyniam Global (OTCPK:KLYG) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Kelyniam Global's Days Sales Outstanding for the quarter that ended in Mar. 2008 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.001	/	0.005	*	91
=	18.25

2. In Ben Graham's calculation of liquidation value, Kelyniam Global's accounts receivable are only considered to be worth 75% of book value:

Kelyniam Global's liquidation value for the quarter that ended in Mar. 2008 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.008	-	0.145	+	0.75 * 0.001	+	0.5 * 0
=	-0.14

Kelyniam Global Change In Receivables Related Terms

Thank you for viewing the detailed overview of Kelyniam Global's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Kelyniam Global (Kelyniam Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kelyniam Global Inc (OTCPK:KLYG) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

97 River Road, Suite A, Canton, CT, USA, 06019

Website

https://www.kelyniam.com

Kelyniam Global Inc is a medical device manufacturing company that specializes in the production of custom skull implants utilizing computer-aided design and bio-compatible medical grade polymers.